LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 55.99 | 771.67 | 6239 | 7690 | 0.8113 | 0.8778 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 58.21 | 771.67 | 5645 | 8085 | 0.6982 | 0.7988 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 58.21 | 771.67 | 6535 | 8085 | 0.8082 | 0.8782 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 60.44 | 771.67 | 5997 | 8530 | 0.7030 | 0.8067 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 60.44 | 771.67 | 6928 | 8530 | 0.8121 | 0.8835 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 62.66 | 771.67 | 6342 | 8978 | 0.7064 | 0.8130 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 62.66 | 771.67 | 7091 | 8978 | 0.7898 | 0.8710 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 64.88 | 771.67 | 6525 | 9447 | 0.6907 | 0.8053 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 64.88 | 771.67 | 7503 | 9447 | 0.7942 | 0.8765 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 67.10 | 771.67 | 6666 | 9800 | 0.6802 | 0.8005 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 67.10 | 771.67 | 7810 | 9800 | 0.7969 | 0.8799 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 69.32 | 771.67 | 6883 | 10212 | 0.6740 | 0.7991 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 69.32 | 771.67 | 8183 | 10212 | 0.8013 | 0.8846 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 71.54 | 771.67 | 6912 | 10532 | 0.6562 | 0.7886 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 71.54 | 771.67 | 8552 | 10532 | 0.8119 | 0.8925 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 73.76 | 771.67 | 6896 | 10851 | 0.6355 | 0.7758 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 73.76 | 771.67 | 9018 | 10851 | 0.8310 | 0.9053 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 76.02 | 771.67 | 6760 | 11106 | 0.6086 | 0.7578 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 76.02 | 771.67 | 9334 | 11106 | 0.8404 | 0.9116 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 78.25 | 771.67 | 6430 | 11367 | 0.5656 | 0.7269 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 78.25 | 771.67 | 9596 | 11367 | 0.8441 | 0.9146 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 80.48 | 771.67 | 6008 | 11685 | 0.5142 | 0.6879 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 80.48 | 771.67 | 10046 | 11685 | 0.8597 | 0.9244 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 82.69 | 771.67 | 5406 | 11974 | 0.4515 | 0.6358 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 82.69 | 771.67 | 10309 | 11974 | 0.8610 | 0.9257 | MN20160304_L01 | M17 |